Cryosite Ltd
ASX:CTE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Spiritus Mundi PLC
LSE:SPMU
|
UK |
|
Can Do Co Ltd
TSE:2698
|
JP |
|
A
|
Aeon Kyushu Co Ltd
TSE:2653
|
JP |
|
Autins Group PLC
LSE:AUTG
|
UK |
Cryosite Ltd
Total Equity
Cryosite Ltd
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Cryosite Ltd
ASX:CTE
|
Total Equity
AU$3.6m
|
CAGR 3-Years
21%
|
CAGR 5-Years
344%
|
CAGR 10-Years
0%
|
|
|
Genetic Technologies Ltd
ASX:GTG
|
Total Equity
-AU$2.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Anteotech Ltd
ASX:ADO
|
Total Equity
AU$2m
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-13%
|
|
|
Proteomics International Laboratories Ltd
ASX:PIQ
|
Total Equity
AU$7.4m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
T
|
Trajan Group Holdings Ltd
ASX:TRJ
|
Total Equity
AU$105.6m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
|
E
|
EZZ Life Science Holdings Ltd
ASX:EZZ
|
Total Equity
AU$28.1m
|
CAGR 3-Years
35%
|
CAGR 5-Years
63%
|
CAGR 10-Years
N/A
|
|
Cryosite Ltd
Glance View
Cryosite Ltd. engages in the provision of long term storage, supply chain logistics management of pharmaceutical products used in clinical trials and biological materials. The company is headquartered in Sydney, New South Wales. The company went IPO on 2002-05-09. The firm operates through two segments, which include Clinical Trials and Biological Services Logistics, and Cord Blood and Tissue Storage. The Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns and biological services to the clinical trial and research industry. The Cord Blood and Tissue Storage segment provides long-term storage for cord blood and tissue samples. The firm engages in clinical trial supply chain from importation, receipt, specialized ambient, cold, frozen, and liquid nitrogen storage for temperature-sensitive products, distribution, and reverse logistics management.
See Also
What is Cryosite Ltd's Total Equity?
Total Equity
3.6m
AUD
Based on the financial report for Dec 31, 2025, Cryosite Ltd's Total Equity amounts to 3.6m AUD.
What is Cryosite Ltd's Total Equity growth rate?
Total Equity CAGR 10Y
0%
Over the last year, the Total Equity growth was 175%. The average annual Total Equity growth rates for Cryosite Ltd have been 21% over the past three years , 344% over the past five years .
